The biggest differences between the two treatment options were major bleeding events and all-cause mortality. There was no significant difference when it came to stroke risk. 

Interventional cardiologists with Henry Ford Health performed the historic procedure on an 85-year-old patient who had been experiencing worsening symptoms for a full year.

“Our results beg the question of whether pre-TAVR baseline coronary angiography is even necessary,” researchers wrote in the American Journal of Cardiology.

We already screen patients for breast cancer and lung cancer on a regular basis. Why not establish screening programs for aortic stenosis?

This represents the latest iteration of the Watchman technology, which was first approved by the FDA back in 2020. 

Researchers explored data from more than 2,300 patients, categorizing all bleeding events based on updated VARC-3 definitions. The team's final analysis was published in JACC: Cardiovascular Interventions.

Temporary changes in cognition, including disorganized thinking, are seen in a significant number of patients following transcatheter aortic valve replacement. 

The study, based on STS/ACC registry data, represents a collaboration between several leading TAVR specialists.